Deutsche Bank
GOSS icon

Deutsche Bank’s Gossamer Bio GOSS Stock Holding History

Deutsche Bank’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Sell
1,106,441
-199,445
-15% -$55.7K ﹤0.01% 3290
2026
Q1 		$431K Buy
1,305,886
+21,551
+2% +$33.9K ﹤0.01% 2651
2025
Q4 		$3.98M Buy
1,284,335
+5,414
+0.4% +$15.4K ﹤0.01% 1415
2025
Q3 		$3.36M Sell
1,278,921
-982,534
-43% -$2.17M ﹤0.01% 1486
2025
Q2 		$2.78M Buy
2,261,455
+148,710
+7% +$162K ﹤0.01% 1521
2025
Q1 		$2.32M Hold
2,112,745
– – ﹤0.01% 1651
2024
Q4 		$1.92M Hold
2,112,745
– – ﹤0.01% 1887
2024
Q3 		$2.09M Sell
2,112,745
-1,694,916
-45% -$1.63M ﹤0.01% 1712
2024
Q2 		$3.43M Hold
3,807,661
– – ﹤0.01% 1379
2024
Q1 		$4.49M Hold
3,807,661
– – ﹤0.01% 1316
2023
Q4 		$3.46M Buy
+3,807,661
New +$2.81M ﹤0.01% 1407
2023
Q3 		– Sell
-162,038
Closed -$194K – 3752
2023
Q2 		$194K Sell
162,038
-47,023
-22% -$58.6K ﹤0.01% 2892
2023
Q1 		$263K Buy
209,061
+10,437
+5% +$20K ﹤0.01% 2870
2022
Q4 		$431K Buy
198,624
+7,785
+4% +$64.1K ﹤0.01% 2533
2022
Q3 		$2.29M Buy
190,839
+151,901
+390% +$1.89M ﹤0.01% 1560
2022
Q2 		$326K Sell
38,938
-1,027
-3% -$7.96K ﹤0.01% 2861
2022
Q1 		$347K Sell
39,965
-21,063
-35% -$203K ﹤0.01% 2958
2021
Q4 		$690K Buy
61,028
+1,297
+2% +$15.4K ﹤0.01% 2638
2021
Q3 		$751K Buy
59,731
+15,951
+36% +$147K ﹤0.01% 2787
2021
Q2 		$356K Buy
43,780
+1,830
+4% +$15.9K ﹤0.01% 3448
2021
Q1 		$388K Sell
41,950
-3,242
-7% -$32.7K ﹤0.01% 3256
2020
Q4 		$437K Sell
45,192
-141,093
-76% -$1.39M ﹤0.01% 2996
2020
Q3 		$2.31M Sell
186,285
-162,824
-47% -$2.16M ﹤0.01% 1656
2020
Q2 		$4.54M Buy
349,109
+334,810
+2,341% +$4.21M ﹤0.01% 1346
2020
Q1 		$146K Sell
14,299
-815
-5% -$10.6K ﹤0.01% 3096
2019
Q4 		$235K Buy
15,114
+3,065
+25% +$61.7K ﹤0.01% 3118
2019
Q3 		$201K Sell
12,049
-7,518
-38% -$149K ﹤0.01% 3195
2019
Q2 		$431K Buy
19,567
+5,513
+39% +$105K ﹤0.01% 3369
2019
Q1 		$303K Buy
+14,054
New +$293K ﹤0.01% 3753

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Deutsche Bank's GOSS Position: Q2 2026 in Review

Deutsche Bank reduced its Gossamer Bio (GOSS) stake by 15% in Q2 2026, selling an estimated $55.7K and leaving 1,106,441 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

Deutsche Bank first reported a position in GOSS in Q1 2019 and has held it in 29 quarters since. The position peaked at $4.54M in Q2 2020. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Deutsche Bank held 1,106,441 shares of Gossamer Bio worth $188K as of Q2 2026.
  • Deutsche Bank sold 199,445 Gossamer Bio shares in Q2 2026, an estimated $55.7K.
  • Gossamer Bio made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3290 holding.
  • Deutsche Bank first reported a position in Gossamer Bio in Q1 2019 and has held it in 29 quarters since.
  • Deutsche Bank's Gossamer Bio position peaked at $4.54M in Q2 2020.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.